-
-
In this issue: New treatment for prostate cancer; avastin and breast cancer; new CMS disclosure rule; and FDA actions.
-
Labial HSV is a remarkably common infection, and is now believed to infect ~70% of the population in the U.S.. Many of these people have only an infrequent outbreak or are unaware of their latent infection.
-
Gillison and colleagues examined the prevalence of oral human papillomavirus (HPV) infections in civilian non-institutionalized individuals 14 69 years of age in the U.S. by conducting a cross-sectional study as part of the National Health and Nutrition Examination Survey (NHANES).
-
US and Afghan patients with positive bacterial culture results from Sept 2007 through August 2008 were reviewed. 266 patients had 411 isolates identified during the study period.
-
Trying to rein in the widespread misuse of antibiotics that is driving the rise of pan-resistant infections, the Centers for Disease Control and Prevention has created an electronic tracking system that will allow hospitals to monitor and benchmark drug use much as they already do for health care associated infections (HAIs).
-
Infection preventionists are keeping their heads above water in a brutal economy, though they may be understandably confused about which hat they have on them.
-
More health care workers than ever are receiving the influenza vaccine. A national survey shows that by mid-November, about 78% of them had been vaccinated a rate that is almost double the rate of about five years ago.
-
Getting a flu shot doesn't provide as much protection as was previously reported, according to new analysis of more than 5,000 studies. Now it's time to be honest about the limitations of the vaccine to build trust with health care workers, says an international expert in risk communication.
-
While emerging multidrug resistant gram negative rods are a prime topic of current concern, there is a sobering reminder that longstanding foes have not exactly been vanquished.